Suvretta Capital Management »

Inmed Pharmaceuticals shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $155k 100k 1.55

More positions owned by Suvretta Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Veradermics Common Stock (MANE)
Arcutis Biotherapeutics (ARQT)
Legend Biotech Corp Sponsored Ads (LEGN)
Palvella Therapeutics Inc Ne (PVLA)
Arrivent Biopharma (AVBP)
Benitec Biopharma Com New (BNTC)
Biohaven (BHVN)
Advanced Micro Devices (AMD)
Arcus Biosciences Incorporated (RCUS)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Eyepoint Com New (EYPT)
SYSCO Corporation (SYY)
Ge Aerospace Com New (GE)

View all positions for Suvretta Capital Management

Top funds holding Inmed Pharmaceuticals

ADAR1 Capital Management
Vivo Capital
Squadron Capital Management
Ikarian Capital
Ursa Fund Management
Suvretta Capital Management
Boothbay Fund Management
Sabby Management
Jane Street
VR Adviser
Citadel Advisors
Seven Grand Managers
Scientech Research
Crestwood Advisors
Two Sigma Securities

View all funds holding Inmed Pharmaceuticals